Flagship Project 7

Advanced and automated innovation labs for diagnostic and therapeutic biopharma solutions

Lead industry: Takis S.r.l., Catalent Anagni S.r.l.
Universities and EPR: Sapienza Università di Roma, Università di Roma Tor Vergata, Università degli Studi Roma Tre, Università degli Studi della Tuscia, Università Campus Bio-Medico di Roma, CNR – Consiglio Nazionale delle Ricerche, INFN – Istituto Nazionale di Fisica Nucleare, Istituto Superiore di Sanità.

The project is aimed to contribute to the development of an advanced open innovation Joint Laboratory focused on the accelerated development of biopharma solutions for enabling innovative characterization and large-scale production of high-affinity monoclonal antibodies for diagnostic and therapeutic applications, and other emerging solutions for relevant pathologies.

This laboratory will be directly shared as Joint Open Lab with the research partners of Rome Technopole specialized on the specific area of bio-pharma and with all the other interested Rome Technopole partners and stakeholders for technology transfer, innovation and training activities


TAKIS S.r.l.: